MFA FINANCIAL, INC.Underwriting Agreement • February 28th, 2020 • Mfa Financial, Inc. • Real estate investment trusts • New York
Contract Type FiledFebruary 28th, 2020 Company Industry JurisdictionMFA Financial, Inc., a Maryland corporation (the “Company”), proposes to issue and sell, severally and not jointly, to the several underwriters listed in Schedule A hereto (collectively, the “Underwriters”), for whom Morgan Stanley & Co. LLC is acting as representative (the “Representative”), 11,000,000 shares (the “Firm Securities”) of 6.50% series C fixed-to-floating rate cumulative redeemable preferred stock, liquidation preference $25.00 per share (the “Series C Preferred Stock”), of the Company. In addition, solely to cover over-allotments, if any, the Company proposes to grant to the Underwriters the option to purchase from the Company up to an additional 1,650,000 shares of Series C Preferred Stock (the “Additional Securities”). The Firm Securities and the Additional Securities are hereinafter collectively sometimes referred to as the “Securities.” The Securities are described in the Prospectus which is referred to below. The Securities will be established by the Articles Supple
MFA FINANCIAL, INC. 50,000,000 Shares Common Stock ($0.01 par value) UNDERWRITING AGREEMENT August 2, 2018Underwriting Agreement • August 7th, 2018 • Mfa Financial, Inc. • Real estate investment trusts • New York
Contract Type FiledAugust 7th, 2018 Company Industry Jurisdiction
MFA FINANCIAL, INC. 20,000,000 Shares Common Stock ($0.01 par value) UNDERWRITING AGREEMENT May 4, 2017Underwriting Agreement • May 9th, 2017 • Mfa Financial, Inc. • Real estate investment trusts • New York
Contract Type FiledMay 9th, 2017 Company Industry Jurisdiction
MFA FINANCIAL, INC.Underwriting Agreement • April 11th, 2012 • Mfa Financial, Inc. • Real estate investment trusts • New York
Contract Type FiledApril 11th, 2012 Company Industry JurisdictionMFA Financial, Inc., a Maryland corporation (the “Company”), proposes to issue and sell, severally and not jointly, to the several underwriters listed in Schedule A hereto (collectively, the “Underwriters”), for whom Morgan Stanley & Co. LLC (“Morgan Stanley”), UBS Securities LLC and Wells Fargo Securities, LLC are acting as representatives (the “Representatives”), $100,000,000 aggregate principal amount of the 8.00% Senior Notes due 2042 (the “Firm Securities”) of the Company. In addition, the Company proposes to grant to the Underwriters the option to purchase from the Company up to an additional $15,000,000 aggregate principal amount of the 8.00% Senior Notes due 2042 (the “Additional Securities”). The Firm Securities and the Additional Securities are hereinafter collectively sometimes referred to as the “Securities.” The Securities are described in the Prospectus which is referred to below.